Department of Abdominal Surgery, Universitair Ziekenhuis Brussel, Jette, Brussel, Belgium.
Surg Endosc. 2012 Aug;26(8):2339-45. doi: 10.1007/s00464-012-2186-7. Epub 2012 Feb 21.
Feasibility and long-term safety of laparoscopic removal of gastric gastrointestinal stromal tumors (GISTs) of the stomach is well established for lesions smaller than 2 cm. Our specific aim was to explore whether laparoscopic treatment is equally applicable for gastric GISTs larger than 2 cm.
Between 1997 and 2010, 31 consecutive patients presenting with a primary gastric GIST were scheduled for laparoscopic resection, irrespective of tumor size. Prerequisites for laparoscopic approach were the absence of metastases and the presence of a well-defined tumor on CT scanning without involvement of adjacent organs, the esophagogastric junction, or the pylorus of the stomach. Data were retrieved retrospectively from a prospectively collected database, including information on patient demographics, surgical procedure, complications, hospital stay, and recurrence. Diagnosis of GIST was based on microscopic analysis, including immunohistochemistry with a panel of antibodies: CD117, CD34, DOG1, S100, desmin, and smooth muscle actin.
All 31 laparoscopic resections were carried out successfully. The most common symptoms were melena, anemia, and abdominal pain. In one case we performed a laparoscopic approach for a GIST with acute bleeding. Tumor size was smaller than 2 cm in 5 patients and larger than 2 cm in 26 patients. The median tumor size was 4.4 cm (range = 0.4-11.0 cm). Median blood loss was identical in both groups (20 ml), but duration of operation (60 vs. 103 min) and duration of hospital stay (6 vs. 8 days) were lower when tumor size was less than 2 cm. Only one patient (with tumor size <2 cm) experienced a postoperative hemorrhage. After a median follow-up of 52 months, there were no recurrences or metastases.
The low morbidity rates and the long-term disease-free interval of 100% observed in our cohort indicate that laparoscopic resection is safe and effective in treating gastric GISTs, even for tumors larger than 2 cm.
腹腔镜切除胃间质瘤(GIST)的可行性和长期安全性已得到充分证实,适用于直径小于 2cm 的病灶。我们的具体目标是探讨腹腔镜治疗是否同样适用于直径大于 2cm 的胃 GIST。
1997 年至 2010 年期间,31 例经组织学证实的胃 GIST 患者,无论肿瘤大小,均接受了腹腔镜切除术。腹腔镜手术的前提是无转移,CT 扫描显示肿瘤边界清楚,无邻近器官、食管胃结合部或胃幽门受累。数据从一个前瞻性收集的数据库中回顾性提取,包括患者人口统计学、手术过程、并发症、住院时间和复发情况等信息。GIST 的诊断基于组织学分析,包括免疫组织化学分析,使用一组抗体:CD117、CD34、DOG1、S100、结蛋白和平滑肌肌动蛋白。
31 例腹腔镜手术均顺利完成。最常见的症状是黑便、贫血和腹痛。有 1 例患者因 GIST 急性出血而行腹腔镜手术。5 例肿瘤直径小于 2cm,26 例肿瘤直径大于 2cm。肿瘤直径中位数为 4.4cm(范围=0.4-11.0cm)。两组患者的术中出血量中位数相同(20ml),但肿瘤直径小于 2cm 的患者手术时间(60min 比 103min)和住院时间(6 天比 8 天)更短。仅有 1 例(肿瘤直径<2cm)患者术后发生出血。中位随访 52 个月后,无复发或转移。
我们的队列中观察到的低发病率和 100%的无病间隔期表明,腹腔镜切除治疗胃 GIST 是安全有效的,即使对于直径大于 2cm 的肿瘤也是如此。